Replication-competent foamy virus vaccine vectors as novel epitope scaffolds for immunotherapy

The use of whole viruses as antigen scaffolds is a recent development in vaccination that improves immunogenicity without the need for additional adjuvants. Previous studies highlighted the potential of foamy viruses (FVs) in prophylactic vaccination and gene therapy. Replication-competent FVs can t...

Full description

Saved in:
Bibliographic Details
Main Authors: Lei, Janet (Author) , Osen, Wolfram (Author) , Gardyan, Adriane (Author) , Hotz-Wagenblatt, Agnes (Author) , Wei, Guochao (Author) , Gissmann, Lutz (Author) , Eichmüller, Stefan B. (Author) , Löchelt, Martin (Author)
Format: Article (Journal)
Language:English
Published: September 23, 2015
In: PLOS ONE
Year: 2015, Volume: 10, Issue: 9
ISSN:1932-6203
DOI:10.1371/journal.pone.0138458
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1371/journal.pone.0138458
Verlag, kostenfrei, Volltext: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0138458
Get full text
Author Notes:Janet Lei, Wolfram Osen, Adriane Gardyan, Agnes Hotz-Wagenblatt, Guochao Wei, Lutz Gissmann, Stefan Eichmüller, Martin Löchelt

MARC

LEADER 00000caa a2200000 c 4500
001 1583844708
003 DE-627
005 20230816134303.0
007 cr uuu---uuuuu
008 181119s2015 xx |||||o 00| ||eng c
024 7 |a 10.1371/journal.pone.0138458  |2 doi 
035 |a (DE-627)1583844708 
035 |a (DE-576)513844708 
035 |a (DE-599)BSZ513844708 
035 |a (OCoLC)1341023832 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Lei, Janet  |e VerfasserIn  |0 (DE-588)1130794644  |0 (DE-627)885188543  |0 (DE-576)487011767  |4 aut 
245 1 0 |a Replication-competent foamy virus vaccine vectors as novel epitope scaffolds for immunotherapy  |c Janet Lei, Wolfram Osen, Adriane Gardyan, Agnes Hotz-Wagenblatt, Guochao Wei, Lutz Gissmann, Stefan Eichmüller, Martin Löchelt 
264 1 |c September 23, 2015 
300 |a 27 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 19.11.2018 
520 |a The use of whole viruses as antigen scaffolds is a recent development in vaccination that improves immunogenicity without the need for additional adjuvants. Previous studies highlighted the potential of foamy viruses (FVs) in prophylactic vaccination and gene therapy. Replication-competent FVs can trigger immune signaling and integrate into the host genome, resulting in persistent antigen expression and a robust immune response. Here, we explored feline foamy virus (FFV) proteins as scaffolds for therapeutic B and T cell epitope delivery in vitro. Infection- and cancer-related B and T cell epitopes were grafted into FFV Gag, Env, or Bet by residue replacement, either at sites of high local sequence homology between the epitope and the host protein or in regions known to tolerate sequence alterations. Modified proviruses were evaluated in vitro for protein steady state levels, particle release, and virus titer in permissive cells. Modification of Gag and Env was mostly detrimental to their function. As anticipated, modification of Bet had no impact on virion release and affected virus titers of only some recombinants. Further evaluation of Bet as an epitope carrier was performed using T cell epitopes from the model antigen chicken ovalbumin (OVA), human tyrosinase-related protein 2 (TRP-2), and oncoprotein E7 of human papillomavirus type 16 (HPV16E7). Transfection of murine cells with constructs encoding Bet-epitope chimeric proteins led to efficient MHC-I-restricted epitope presentation as confirmed by interferon-gamma enzyme-linked immunospot assays using epitope-specific cytotoxic T lymphocyte (CTL) lines. FFV infection-mediated transduction of cells with epitope-carrying Bet also induced T-cell responses, albeit with reduced efficacy, in a process independent from the presence of free peptides. We show that primate FV Bet is also a promising T cell epitope carrier for clinical translation. The data demonstrate the utility of replication-competent and -attenuated FVs as antigen carriers in immunotherapy. 
650 4 |a 293T cells 
650 4 |a Enzyme-linked immunoassays 
650 4 |a Sequence motif analysis 
650 4 |a T cells 
650 4 |a Vector-borne diseases 
650 4 |a Viral replication 
650 4 |a Viral vectors 
650 4 |a Virions 
700 1 |a Osen, Wolfram  |d 1963-  |e VerfasserIn  |0 (DE-588)114590789X  |0 (DE-627)1007012056  |0 (DE-576)172955033  |4 aut 
700 1 |a Gardyan, Adriane  |e VerfasserIn  |0 (DE-588)1050052986  |0 (DE-627)783252331  |0 (DE-576)322464595  |4 aut 
700 1 |a Hotz-Wagenblatt, Agnes  |e VerfasserIn  |0 (DE-588)1163289310  |0 (DE-627)1027495982  |0 (DE-576)507876806  |4 aut 
700 1 |a Wei, Guochao  |d 1988-  |e VerfasserIn  |0 (DE-588)1155885589  |0 (DE-627)1018364463  |0 (DE-576)501928189  |4 aut 
700 1 |a Gissmann, Lutz  |d 1949-  |e VerfasserIn  |0 (DE-588)1153082020  |0 (DE-627)1014479541  |0 (DE-576)500060126  |4 aut 
700 1 |a Eichmüller, Stefan B.  |d 1960-  |e VerfasserIn  |0 (DE-588)1025289226  |0 (DE-627)721986951  |0 (DE-576)37016704X  |4 aut 
700 1 |a Löchelt, Martin  |e VerfasserIn  |0 (DE-588)1106411617  |0 (DE-627)863134173  |0 (DE-576)165786078  |4 aut 
773 0 8 |i Enthalten in  |t PLOS ONE  |d San Francisco, California, US : PLOS, 2006  |g 10(2015), 9, Artikel-ID e0138458  |h Online-Ressource  |w (DE-627)523574592  |w (DE-600)2267670-3  |w (DE-576)281331979  |x 1932-6203  |7 nnas  |a Replication-competent foamy virus vaccine vectors as novel epitope scaffolds for immunotherapy 
773 1 8 |g volume:10  |g year:2015  |g number:9  |g elocationid:e0138458  |g extent:27  |a Replication-competent foamy virus vaccine vectors as novel epitope scaffolds for immunotherapy 
856 4 0 |u http://dx.doi.org/10.1371/journal.pone.0138458  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0138458  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20181119 
993 |a Article 
994 |a 2015 
998 |g 1106411617  |a Löchelt, Martin  |m 1106411617:Löchelt, Martin  |d 50000  |e 50000PL1106411617  |k 0/50000/  |p 8  |y j 
998 |g 1025289226  |a Eichmüller, Stefan B.  |m 1025289226:Eichmüller, Stefan B.  |d 140000  |d 60000  |e 140000PE1025289226  |e 60000PE1025289226  |k 0/140000/  |k 0/60000/  |p 7 
998 |g 1155885589  |a Wei, Guochao  |m 1155885589:Wei, Guochao  |d 50000  |e 50000PW1155885589  |k 0/50000/  |p 5 
998 |g 1163289310  |a Hotz-Wagenblatt, Agnes  |m 1163289310:Hotz-Wagenblatt, Agnes  |d 140000  |e 140000PH1163289310  |k 0/140000/  |p 4 
998 |g 114590789X  |a Osen, Wolfram  |m 114590789X:Osen, Wolfram  |d 50000  |e 50000PO114590789X  |k 0/50000/  |p 2 
999 |a KXP-PPN1583844708  |e 3032695880 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"27 S."}],"relHost":[{"disp":"Replication-competent foamy virus vaccine vectors as novel epitope scaffolds for immunotherapyPLOS ONE","type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Schreibweise des Titels bis 2012: PLoS ONE","Gesehen am 20.03.19"],"language":["eng"],"corporate":[{"role":"isb","roleDisplay":"Herausgebendes Organ","display":"Public Library of Science"}],"recId":"523574592","pubHistory":["1.2006 -"],"part":{"issue":"9","year":"2015","extent":"27","text":"10(2015), 9, Artikel-ID e0138458","volume":"10"},"title":[{"title_sort":"PLOS ONE","title":"PLOS ONE"}],"physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["Public Library of Science"]},"origin":[{"dateIssuedDisp":"2006-","dateIssuedKey":"2006","publisher":"PLOS ; PLoS","publisherPlace":"San Francisco, California, US ; Lawrence, Kan."}],"id":{"issn":["1932-6203"],"eki":["523574592"],"zdb":["2267670-3"]}}],"origin":[{"dateIssuedDisp":"September 23, 2015","dateIssuedKey":"2015"}],"id":{"eki":["1583844708"],"doi":["10.1371/journal.pone.0138458"]},"name":{"displayForm":["Janet Lei, Wolfram Osen, Adriane Gardyan, Agnes Hotz-Wagenblatt, Guochao Wei, Lutz Gissmann, Stefan Eichmüller, Martin Löchelt"]},"note":["Gesehen am 19.11.2018"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1583844708","language":["eng"],"title":[{"title_sort":"Replication-competent foamy virus vaccine vectors as novel epitope scaffolds for immunotherapy","title":"Replication-competent foamy virus vaccine vectors as novel epitope scaffolds for immunotherapy"}],"person":[{"roleDisplay":"VerfasserIn","display":"Lei, Janet","role":"aut","family":"Lei","given":"Janet"},{"family":"Osen","given":"Wolfram","roleDisplay":"VerfasserIn","display":"Osen, Wolfram","role":"aut"},{"display":"Gardyan, Adriane","roleDisplay":"VerfasserIn","role":"aut","family":"Gardyan","given":"Adriane"},{"role":"aut","display":"Hotz-Wagenblatt, Agnes","roleDisplay":"VerfasserIn","given":"Agnes","family":"Hotz-Wagenblatt"},{"family":"Wei","given":"Guochao","roleDisplay":"VerfasserIn","display":"Wei, Guochao","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Gissmann, Lutz","role":"aut","family":"Gissmann","given":"Lutz"},{"display":"Eichmüller, Stefan B.","roleDisplay":"VerfasserIn","role":"aut","family":"Eichmüller","given":"Stefan B."},{"role":"aut","display":"Löchelt, Martin","roleDisplay":"VerfasserIn","given":"Martin","family":"Löchelt"}]} 
SRT |a LEIJANETOSREPLICATIO2320